Abstract：
In 2021, the National Institute for Health and Care Excellence produced an evidence-based guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a disabling long-term condition of unknown cause. The guideline provides clear support for people living with ME/CFS, their families and carers, and for clinicians. A recent opinion piece published in the journal suggested that there were anomalies in the processing and interpretation of the evidence when developing the guideline and proposed eight areas where these anomalies were thought to have occurred. We outline how these opinions are based on a misreading or misunderstanding of the guideline process or the guideline, which provides a balanced and reasoned approach to the diagnosis and management of this challenging condition.
摘要：
2021年，美国国家健康与护理卓越研究所针对肌痛性脑脊髓炎/慢性疲劳综合征（ME/CFS）的诊断和管理制定了基于证据的指南。原因不明的长期残疾状况。该指南为生活在ME/CFS中的人们提供了明确的支持，他们的家人和看护人,和临床医生。最近发表在该杂志上的一篇观点文章表明，在制定指南时，证据的处理和解释存在异常，并提出了八个被认为发生这些异常的领域。我们概述了这些意见是如何基于对指南过程或指南的误读或误解，这为这种具有挑战性的疾病的诊断和管理提供了平衡和合理的方法。
